信息

信息
CTO Nakayama Contributes Invited Article to Experimental Medicine, Japan’s Leading Life Science Journal, on AI-Driven Drug Discovery
2026年3月12日

株式会社GEXValMarch 12, 2026 CTO Nakayama Contributes Invited Article to Experimental Medicine Special Issue on AI […]

Read more
信息
Rare Disease Day Update: FRAXA Features GEXVal’s FRAXA-DVI Completion and FDA Orphan Drug Designation
2026年2月28日

GEXVal Inc.February 28, 2026 FRAXA Research Foundation Features GEXVal's Completion of FRAXA-DVI Program and F […]

Read more
信息
GEXVal Selected as Presenting Company at Biotech Showcase™ 2026
2026年1月7日

株式会社GEXValJanuary 7, 2026 GEXVal Selected as Presenting Company at Biotech Showcase™ 2026 GEXVal Inc. (Preside […]

Read more
信息
GEXVal Featured in BioCentury Article
2025年12月22日

株式会社GEXValDecember 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Lev […]

Read more
信息
GEXVal Senior Director Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025年12月12日

株式会社GEXValDecember 12, 2025 GEXVal Senior Director Delivers Lecture at University of Tokyo Hospital TR/Academi […]

Read more